The use of anti-asthmatic medications among pediatric patients in Taiwan
The use of anti-asthmatic medications among pediatric patients in Taiwan
复制标题
DOI：
10.1002/pds.810
复制
发表时间：
2003-03-01
影响因子：
2.6
通讯作者：
Yang, CY
中科院分区：
文献类型：
--
作者：
Chen, CY;Chiu, HF;Yang, CY
目的描述台湾地区儿童哮喘患者使用抗哮喘药物的情况。方法使用国家健康保险局数据库中的数据，分析18岁以下哮喘患者的用药模式和程度。药物根据解剖治疗化学（ATC）的分类system.Results数据共290467名儿童被列入研究。总体而言，患者更频繁地接受口服药物治疗。69.43%和40.24%的患者分别使用口服β受体激动剂（OBA）和甲基黄嘌呤。OBA单药治疗是最受欢迎的方案，占研究处方总数的13.70%。仅6.70%的患者使用吸入性皮质类固醇（ICS）。在研究期间，ICS的用户使用的平均1.65 canisters.Conclusions目前的做法，在台湾的哮喘管理达不到国际准则中规定的目标。抗炎药在台湾儿科患者中使用不足。版权所有（C）2003约翰威利父子有限公司。
Purpose To describe the use of anti-asthma drugs in Taiwanese pediatric patients.Methods Using the data from the database of Bureau of National Health Insurance, we analyze the patterns and extent of medication use among asthma patients less than 18 years old. Drugs were classified according to the Anatomical Therapeutic Chemical (ATC) Classification system.Results Data on a total of 290467 children were included in the study. Overall, patients were treated more frequently with oral medications. 69.43 and 40.24% of patients were using oral beta-agonists (OBAs) and methylxanthines respectively. Monotherapy with OBAs was the most popular regimen, accounting for 13.70% of the total prescriptions studied. Only 6.70% of patients were taking inhaled corticosteroids (ICSs). During the studied period, users of ICSs were using an average of 1.65 canisters.Conclusions The Current practices of asthma management in Taiwan fall short of the goals stated in international guidelines. Anti-inflammatory agents were being underused in Taiwanese pediatric patients. Copyright (C) 2003 John Wiley Sons, Ltd.